MARKET

AZN

AZN

Astrazeneca Plc
NASDAQ
91.93
-0.58
-0.63%
After Hours: 92.61 +0.68 +0.74% 19:01 12/31 EST
OPEN
92.25
PREV CLOSE
92.51
HIGH
92.48
LOW
91.92
VOLUME
2.10M
TURNOVER
--
52 WEEK HIGH
94.02
52 WEEK LOW
60.82
MARKET CAP
285.12B
P/E (TTM)
30.54
1D
5D
1M
3M
1Y
5Y
1D
Pfizer, GSK and other drugmakers eying U.S. price hikes for 350 medicines: report
Seeking Alpha · 12/31/2025 13:22
The Zacks Analyst Blog Highlights Berkshire Hathaway, AstraZeneca, Intel, Kingsway Financial and BK Technologies
NASDAQ · 12/31/2025 12:01
Top Stock Reports for Berkshire Hathaway, AstraZeneca & Intel
NASDAQ · 12/30/2025 19:04
Judge Halts US Drug Discount Overhaul, Blocks 340B Rebate Plan
Benzinga · 12/30/2025 14:41
Mereo Biopharma Stock (MREO) Collapses over 90% after Failed Trials
TipRanks · 12/29/2025 16:34
My Market Outlook For 2026: Focus On Pharma For Consistent Returns, Potential Skyrocketing Shares
Seeking Alpha · 12/29/2025 16:00
2026 S&P 500 Outlook: Look For Pharma Sector To Lead The Way With Potential Changes
Seeking Alpha · 12/29/2025 14:20
Alibaba Was the Market’s Favorite Chinese AI Stock in 2025: What’s BABA’s 2026 Forecast?
Barchart · 12/29/2025 13:20
More
About AZN
AstraZeneca PLC is a United Kingdom-based science-led biopharmaceutical company. The Company focuses on the discovery, development, and commercialization of prescription medicines. The Company operates across therapy areas, including Oncology; Cardiovascular, Renal and Metabolism (CVRM); Respiratory and Immunology (R&I); Vaccines and Immune Therapies (V&I), and Rare Disease. In the Oncology area, its key products include Tagrisso, Imfinzi, Calquence, Lynparza, and Enhertu. The key products of CVRM area include Farxiga/Forxiga, Brilinta/Brilique, Crestor, and Lokelma. In the R&I area, the key products are Symbicort, Fasenra, Breztri/Trixeo, and Tezspire. In the V&I Therapies area, the products are Beyfortus and FluMist. The products in the Rare Disease area are Ultomiris, Soliris, Strensiq, and Koselugo. It has about 191 projects in its development pipeline, including 19 new molecular entities (NMEs) in the late-stage pipeline. The Company distributes its products in over 125 countries.

Webull offers AstraZeneca PLC (ADR) stock information, including NASDAQ: AZN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AZN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AZN stock methods without spending real money on the virtual paper trading platform.